Diabetes mellitus and exocrine pancreatic insufficiency (review of literature)

Main Article Content

L.T. Daminova
S.U. Muminova


Currently, an increasing importance is given to the study of the problem of exocrine pancreatic insufficiency, which is observed in a significant number of patients with diabetes mellitus (DM) type 1 and 2 and can potentially affect the compensation of DM. The mechanism of reducing the external secretion of the pancreas in DM is associated with an imbalance of inhibitory and stimulating pancreatic secretion of hormones, with fibrosis of the gland as a result of diabetic angiopathy. In type 2 DM, the mechanisms that result from the metabolic syndrome are involved in the pathogenesis of exocrine pancreatic insufficiency. Enzyme replacement the­rapy should be considered as one of the promising methods of treating DM patients.

Article Details

How to Cite
Daminova, L., and S. Muminova. “Diabetes Mellitus and Exocrine Pancreatic Insufficiency (review of Literature)”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 14, no. 1, Mar. 2018, pp. 55-58, doi:10.22141/2224-0721.14.1.2018.127093.
Literature Review


Gubergrits NB. Modern Achievements of European Pancreatology (Following 44th Meeting of European Pancreatic Club). Gastroenterologìa. 2013;(47):13-18. (in Russian).

Demicheva TP, Tsimmerman IY. Condition of exocrinous function of pancreas among patients with pancreatic diabetes and chronic pancreatitis. Meditsinskii al'manakh. 2011;(2):66-67. (in Russian).

Larin AS, Tkach SM, Yuzvenko TYu. Diagnostics and correction of pancreas exocrine insufficiency in patients with diabetes mellitus. Mìžnarodnij endokrinologìčnij žurnal. 2006;(5):34-37. (in Russsian).

Nagornaya NV, Limarenko MP. Exocrine function of pancreas and methods of its estimation. Zdorovʹe rebenka. 2012;(43):61-67. (in Russian).

Tkach SM, Shvets OV. Modern Approaches to Optimization of the Diagnosis and Treatment of Exocrine Pancreatic Insufficiency. Gastroenterologìa. 2014;(51):13-18. (in Russian).

Ferrer R, Medrano J, Diego M, et al. Effect of exogenous insulin and glucagon on exocrine pancreatic secretion in rats in vivo. Int J Pancreatol. 2000 Aug;28(1):67-75. doi: 10.1385/IJGC:28:1:67.

Dominguez-Munoz JE. Chronic pancreatitis and persistent steatorrhea: what is the correct dose of enzymes? Clin Gastroenterol Hepatol. 2011 Jul;9(7):541-6. doi: 10.1016/j.cgh.2011.02.027.

Schafer E, Fekete A, Gasparics R, et al. A comparatives study of diabetic complications in patients with pancreatic diabetes mellitus and chronic pancreatitis. Pancreatology. 2009;6:375.

Williams AJ, Thrower SL, Sequeiros IM, et al. Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes. J Clin Endocrinol Metab. 2012 Nov;97(11):E2109-13. doi: 10.1210/jc.2012-1815.

Chandra R, Liddle RA. Modulation of pancreatic exocrine and endocrine secretion. Curr Opin Gastroenterol. 2013 Sep;29(5):517-22. doi: 10.1097/MOG.0b013e3283639326.

Eberhard D, Lammert E. The pancreatic beta-cell in the islet and organ community. Curr Opin Genet Dev. 2009 Oct;19(5):469-75. doi: 10.1016/j.gde.2009.07.003.

Piciucchi M, Capurso G, Archibugi L, Delle Fave MM, Capasso M, Delle FG. Exocrine pancreatic insufficiency in diabetic patients: prevalence, mechanisms, and treatment. Int J Endocrinol. 2015;2015:595649. doi: 10.1155/2015/595649.

Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012 May;28(4):338-42. doi: 10.1002/dmrr.2260. 

Gaglia JL, Guimaraes AR, Harisinghani M, et al. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest. 2011 Jan;121(1):442-5. doi: 10.1172/JCI44339.

Muniraj T, Aslanian HR, Farrell J, Jamidar PA. Chronic pancreatitis, a comprehensive review and update. Part I: epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features. Dis Mon. 2014 Dec;60(12):530-50. doi: 10.1016/j.disamonth.2014.11.002.

Coppieters KT, Dotta F, Amirian N, et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med. 2012 Jan 16;209(1):51-60. doi: 10.1084/jem.20111187.